Topics

IP Explained: Myth vs. fact about strong patent protections in the biopharmaceutical industry

13:09 EDT 2 May 2019 | PhRMA

Strong patent protections are fundamental to the creation of new treatments and cures that extend and improve patients’ lives. In recent years, critics of the biopharmaceutical industry have suggested otherwise by advancing misleading and inaccurate narratives that mischaracterize the role of patents, the value of new treatment advances and the nature of competition in the biopharmaceutical industry. Robust intellectual property (IP) protections, including patents, fuel biopharmaceutical innovation and promote competition in the marketplace.

Original Article: IP Explained: Myth vs. fact about strong patent protections in the biopharmaceutical industry

NEXT ARTICLE

More From BioPortfolio on "IP Explained: Myth vs. fact about strong patent protections in the biopharmaceutical industry"

Quick Search

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...